Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Allogene Therapeutics (ALLO) Prepaid Assets (2019 - 2025)

Allogene Therapeutics (ALLO) has disclosed Prepaid Assets for 7 consecutive years, with $7.5 million as the latest value for Q4 2025.

  • Quarterly Prepaid Assets fell 30.9% to $7.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.5 million through Dec 2025, down 30.9% year-over-year, with the annual reading at $7.5 million for FY2025, 30.9% down from the prior year.
  • Prepaid Assets hit $7.5 million in Q4 2025 for Allogene Therapeutics, down from $8.5 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $22.5 million in Q2 2022 to a low of $7.5 million in Q4 2025.
  • Historically, Prepaid Assets has averaged $12.9 million across 5 years, with a median of $11.5 million in 2022.
  • Biggest five-year swings in Prepaid Assets: soared 1548.0% in 2021 and later tumbled 55.01% in 2023.
  • Year by year, Prepaid Assets stood at $14.0 million in 2021, then fell by 17.95% to $11.5 million in 2022, then dropped by 9.44% to $10.4 million in 2023, then rose by 4.72% to $10.9 million in 2024, then plummeted by 30.9% to $7.5 million in 2025.
  • Business Quant data shows Prepaid Assets for ALLO at $7.5 million in Q4 2025, $8.5 million in Q3 2025, and $9.5 million in Q2 2025.